What specific supplier control issues are FDA citing under QMSR?
Answered at 5:15 in #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls · Global Medical Device Podcast powered by Greenlight Guru
What specific supplier control issues are FDA citing under QMSR?
Supplier audit reports used to be exempt from routine FDA review, so they were written candidly with open issues. Now these records are real regulatory evidence. Additionally, most supplier programs are uniform when the standard requires them to be proportionate to the risk. For example, a label printing supplier and an implant supplier should not receive the same questionnaire and three-year audit cycle. If you don't have a proportionate program based on supplier risk to the product, it's evidence you haven't applied risk-based thinking to purchasing.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
Supplier audit reports used to be exempt from routine FDA review, so they were written candidly with open issues.
Nikhil Mangali, Vice President of Quality at Capstone Medical · #474: Behind the QMSR Audits: The Top 5 FDA Citations & Risk Management Pitfalls · Global Medical Device Podcast powered by Greenlight Guru · answer at 5:15
Key takeaways
- Supplier audit reports used to be exempt from routine FDA review, so they were written candidly with open issues.
Quote to remember
“Your own risk documentation tells you that. Your own file is now the navigation instrument for an investigator.”
— Nikhil Mangali
The full answer · about 5 min
Supplier audit reports used to be exempt from routine FDA review, so they were written candidly with open issues. Now these records are real regulatory evidence. Additionally, most supplier programs are uniform when the standard requires them to be proportionate to the risk. For example, a label printing supplier and an implant supplier should not receive the same questionnaire and three-year audit cycle. If you don't have a proportionate program based on supplier risk to the product, it's evidence you haven't applied risk-based thinking to purchasing.
Key facts
- QMSR effective for seven months at time of episode recording
- Proposed rule released three and a half years before QMSR implementation
- Risk management process must run through product realization under ISO 13485 Clause 7.3, not just at design validation
- FDA compliance program organizes inspection around six QMS areas plus four FDA-specific requirements
- July 2024: Nikhil Mangali promoted to Vice President of Quality at Capstone Medical
People, companies and topics mentioned
More answers from this episode
- 0:54What are the top 5 FDA citations from QMSR audits according to real inspection data?
- 3:00Why is risk management the most cited QMSR compliance violation?
- 14:20How should legacy medical devices with older DHF files approach QMSR compliance?
- 17:45What are the three layers of DHF to ISO 13485 mapping and what do most companies miss?
- 20:10What is the four-phase gap assessment process for QMSR compliance?